Category Archives: FDA

FDA Accepts First Biosimilar Application for Review

In an important step forward for the introduction of “generic biological,” the FDA announced that it has accepted Sandoz’s application to market a generic version of Amgen’s Neupogen®, which stimulates white blood cell production. As you may recall, about two years … Continue reading

Posted in FDA | Tagged , , , , , , , , , , , , | Leave a comment